Torrent Pharmaceuticals
From Wikipedia, the free encyclopedia
| Torrent Pharmaceuticals Limited | |
|---|---|
| Type | Public (BSE: TORRENTPH) |
| Founded | 1959 |
| Headquarters | Ahmedabad, India |
| Key people | Sudhir Mehta, Chairman |
| Industry | Pharmaceuticals |
| Revenue | ▲INR 13.3 billion (2007) |
| Net income | ▲INR 0.9 billion (2007) |
| Employees | 4000 (2006) |
| Website | www.torrentpharma.com/ |
Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group. Based in Ahmedabad, it was promoted by U. N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name Torrent Pharmaceuticals Ltd.
Torrent Pharmaceuticals operates in more than 50 countries with over 1000 product registrations globally. Moreover, it has 5 fully owned subsidiares:
- Torrent do Brasila in Brazil
- Torrent Pharma Gmbh in Germany
- Torrent Pharma Ltd. in the Philippines
- Zao Torrent in Russia
- Torrent Pharma Inc. in USA
Torrent Pharmaceuticals acquired Heumann Gmbh, a Pfizer group company in 2005.
[edit] External links
  |
This article on an Indian company is a stub. You can help Wikipedia by expanding it. |
 |
This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |
